ANIP insider Form 4: 400-share sale by SVP at $90.09
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ANI Pharmaceuticals (ANIP) reported an insider transaction on a Form 4. Senior Vice President, General Counsel & Secretary Meredith W. Cook sold 400 shares of common stock on 10/13/2025 at $90.09 per share under a Rule 10b5-1 trading plan adopted on September 17, 2024.
Following the sale, Cook beneficially owns 75,674 shares, held directly. This filing reflects routine insider activity disclosed for transparency.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 400 shares ($36,036)
Net Sell
1 txn
Insider
Cook Meredith
Role
SR. VP, GENERAL COUNSEL & SEC.
Sold
400 shs ($36K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 400 | $90.09 | $36K |
Holdings After Transaction:
Common Stock — 75,674 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did ANIP report?
A Form 4 disclosed that Meredith W. Cook sold 400 shares of common stock.
When did the ANIP insider sale occur?
The transaction date was 10/13/2025.
Who is the ANIP insider involved in this Form 4?
Senior Vice President, General Counsel & Secretary Meredith W. Cook.
Was the ANIP sale under a 10b5-1 plan?
Yes. It was effected pursuant to a Rule 10b5-1 trading plan adopted on September 17, 2024.